Statins inhibit tumor cells proliferation by their effect on cell cycle by blocking the transition from G1 to S phase, this arrest is mediated by downregulation of cyclin-dependent kinase-2 (CDK-2) activity, and upregulation and stabilization of CDK inhibitors p21 and p27 [21, 22]. This evidence concerns the gene CDK2 and neoplasm.